211 related articles for article (PubMed ID: 30668388)
1. Piperine enhances the bioavailability of silybin via inhibition of efflux transporters BCRP and MRP2.
Bi X; Yuan Z; Qu B; Zhou H; Liu Z; Xie Y
Phytomedicine; 2019 Feb; 54():98-108. PubMed ID: 30668388
[TBL] [Abstract][Full Text] [Related]
2. Baicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2.
Xu P; Zhou H; Li YZ; Yuan ZW; Liu CX; Liu L; Xie Y
Front Pharmacol; 2018; 9():1115. PubMed ID: 30416442
[TBL] [Abstract][Full Text] [Related]
3. Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies.
Yuan ZW; Li YZ; Liu ZQ; Feng SL; Zhou H; Liu CX; Liu L; Xie Y
Pharmacol Res; 2018 Feb; 128():153-166. PubMed ID: 28958806
[TBL] [Abstract][Full Text] [Related]
4. Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies.
Jin X; Zhang ZH; Sun E; Tan XB; Li SL; Cheng XD; You M; Jia XB
Int J Nanomedicine; 2013; 8():641-52. PubMed ID: 23426652
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Oral Bioavailability of Domperidone with Piperine in Male Wistar Rats: Involvement of CYP3A1 and P-gp Inhibition.
Athukuri BL; Neerati P
J Pharm Pharm Sci; 2017; 20():28-37. PubMed ID: 28459658
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral bioavailability of piperine by self-emulsifying drug delivery systems: in vitro, in vivo and in situ intestinal permeability studies.
Shao B; Cui C; Ji H; Tang J; Wang Z; Liu H; Qin M; Li X; Wu L
Drug Deliv; 2015; 22(6):740-7. PubMed ID: 24670090
[TBL] [Abstract][Full Text] [Related]
7. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
[TBL] [Abstract][Full Text] [Related]
8. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
[TBL] [Abstract][Full Text] [Related]
9. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
Xiao L; Yi T; Chen M; Lam CW; Zhou H
Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
[TBL] [Abstract][Full Text] [Related]
10. Effects of piperine on the intestinal permeability and pharmacokinetics of linarin in rats.
Feng X; Liu Y; Wang X; Di X
Molecules; 2014 Apr; 19(5):5624-33. PubMed ID: 24786847
[TBL] [Abstract][Full Text] [Related]
11. The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells.
Ye L; Yang X; Yang Z; Gao S; Yin T; Liu W; Wang F; Hu M; Liu Z
Toxicol Lett; 2013 Feb; 216(2-3):86-99. PubMed ID: 23200901
[TBL] [Abstract][Full Text] [Related]
12. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
Yu D; Kan Z; Shan F; Zang J; Zhou J
Mol Pharm; 2020 Dec; 17(12):4443-4462. PubMed ID: 32926628
[TBL] [Abstract][Full Text] [Related]
13. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
Cherniakov I; Izgelov D; Domb AJ; Hoffman A
Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications.
Naseem A; Pal A; Gowan S; Asad Y; Donovan A; Temesszentandrási-Ambrus C; Kis E; Gaborik Z; Bhalay G; Raynaud F
Cells; 2022 Oct; 11(20):. PubMed ID: 36291153
[TBL] [Abstract][Full Text] [Related]
15. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
Cherniakov I; Izgelov D; Barasch D; Davidson E; Domb AJ; Hoffman A
J Control Release; 2017 Nov; 266():1-7. PubMed ID: 28890215
[TBL] [Abstract][Full Text] [Related]
16. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
[TBL] [Abstract][Full Text] [Related]
17. Effect of piperine on the bioavailability and pharmacokinetics of emodin in rats.
Di X; Wang X; Di X; Liu Y
J Pharm Biomed Anal; 2015 Nov; 115():144-9. PubMed ID: 26201645
[TBL] [Abstract][Full Text] [Related]
18. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells.
Li S; Lei Y; Jia Y; Li N; Wink M; Ma Y
Phytomedicine; 2011 Dec; 19(1):83-7. PubMed ID: 21802927
[TBL] [Abstract][Full Text] [Related]
19. Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance.
Kwatra D; Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
Int J Pharm; 2010 Aug; 395(1-2):114-21. PubMed ID: 20573570
[TBL] [Abstract][Full Text] [Related]
20. Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors.
Syed SB; Lin SY; Arya H; Fu IH; Yeh TK; Charles MRC; Periyasamy L; Hsieh HP; Coumar MS
Chem Biol Drug Des; 2021 Jan; 97(1):51-66. PubMed ID: 32633857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
